Guaynabo, PR, United States
ActiPharma, Inc. recalls
1 recall recorded since 2018, most recently on 28 September 2023. None are listed as ongoing. Status and classification are as published by the FDA.
Recalls1
Ongoing (FDA)0
Terminated or completed1
Class I (FDA)0
Terminated Class III Food
- Recall started
- 28 September 2023
- Terminated
- 16 January 2024
- Reason
- FDA sample analysis of ACTIRON Dietary Supplement, 100 Tablets, Lot 13309, found the product did not meet folic acid specification compared to the label claim.
- Distribution
- Domestic distribution, in Puerto Rico.
- Initiated
- Voluntary: Firm initiated
- Recall number
- F-0463-2024
- ACTIRON Dietary Supplement, ActiPharma, 100 tablets (24 bottles per case) ) (Lot 13309, Exp.: 01/26), UPC: 363102217104.
A terminated FDA recall means the FDA has determined that all reasonable efforts to remove or correct the product have been made. What statuses mean.